West Pharmaceutical Services Total Current Assets decreased by 7.7% to $1.83B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.3%, from $1.46B to $1.83B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 7.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.48B | $1.60B | $1.74B | $1.69B | $1.77B | $1.73B | $1.92B | $1.94B | $1.87B | $1.97B | $1.94B | $1.69B | $1.48B | $1.55B | $1.54B | $1.46B | $1.68B | $1.82B | $1.98B | $1.83B |
| QoQ Change | — | +8.2% | +9.0% | -3.0% | +4.8% | -2.1% | +10.7% | +0.9% | -3.3% | +5.2% | -1.8% | -12.6% | -12.4% | +4.6% | -0.8% | -5.2% | +15.3% | +8.5% | +8.5% | -7.7% |
| YoY Change | — | — | — | — | +19.9% | +8.5% | +10.2% | +14.6% | +5.8% | +13.8% | +0.9% | -12.6% | -20.9% | -21.4% | -20.6% | -13.9% | +13.3% | +17.6% | +28.6% | +25.3% |